ICU Medical, Inc. (NASDAQ:ICUI) Short Interest Update

ICU Medical, Inc. (NASDAQ:ICUI) was the recipient of a large increase in short interest in December. As of December 31st, there was short interest totalling 838,100 shares, an increase of 14.0% from the December 15th total of 735,400 shares. Based on an average daily trading volume, of 217,900 shares, the days-to-cover ratio is currently 3.8 days. Currently, 3.7% of the shares of the stock are short sold.

Insider Activity at ICU Medical

In other ICU Medical news, CEO Vivek Jain sold 1,373 shares of ICU Medical stock in a transaction dated Thursday, January 2nd. The stock was sold at an average price of $155.48, for a total value of $213,474.04. Following the completion of the sale, the chief executive officer now owns 104,593 shares in the company, valued at $16,262,119.64. The trade was a 1.30 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, Director David C. Greenberg sold 972 shares of the stock in a transaction that occurred on Wednesday, November 27th. The stock was sold at an average price of $158.11, for a total transaction of $153,682.92. Following the transaction, the director now directly owns 5,037 shares in the company, valued at approximately $796,400.07. This represents a 16.18 % decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 29,737 shares of company stock valued at $4,941,832. 6.70% of the stock is owned by corporate insiders.

Institutional Inflows and Outflows

Several institutional investors have recently modified their holdings of the business. Millennium Management LLC increased its holdings in ICU Medical by 327.8% during the 2nd quarter. Millennium Management LLC now owns 136,070 shares of the medical instruments supplier’s stock worth $16,158,000 after purchasing an additional 104,264 shares during the last quarter. FMR LLC grew its position in shares of ICU Medical by 2,676.6% during the third quarter. FMR LLC now owns 104,094 shares of the medical instruments supplier’s stock worth $18,968,000 after buying an additional 100,345 shares in the last quarter. Granite Investment Partners LLC bought a new stake in shares of ICU Medical in the second quarter worth $10,650,000. State Street Corp raised its holdings in ICU Medical by 9.3% in the third quarter. State Street Corp now owns 907,607 shares of the medical instruments supplier’s stock valued at $165,384,000 after acquiring an additional 77,506 shares in the last quarter. Finally, Dimensional Fund Advisors LP boosted its stake in ICU Medical by 21.7% during the 2nd quarter. Dimensional Fund Advisors LP now owns 311,542 shares of the medical instruments supplier’s stock valued at $36,996,000 after acquiring an additional 55,588 shares during the last quarter. Institutional investors and hedge funds own 96.10% of the company’s stock.

ICU Medical Price Performance

Shares of ICUI stock opened at $163.87 on Monday. The firm has a fifty day simple moving average of $161.73 and a 200-day simple moving average of $159.45. The company has a market capitalization of $4.01 billion, a PE ratio of -35.86 and a beta of 0.63. ICU Medical has a twelve month low of $86.80 and a twelve month high of $196.26. The company has a current ratio of 2.29, a quick ratio of 1.03 and a debt-to-equity ratio of 0.75.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently issued reports on the stock. Jefferies Financial Group raised shares of ICU Medical from a “hold” rating to a “buy” rating and set a $200.00 price objective for the company in a research report on Wednesday, December 11th. StockNews.com raised ICU Medical from a “hold” rating to a “buy” rating in a research report on Wednesday, November 20th. KeyCorp boosted their price objective on ICU Medical from $198.00 to $209.00 and gave the stock an “overweight” rating in a research note on Wednesday, November 13th. Finally, Needham & Company LLC reiterated a “hold” rating on shares of ICU Medical in a research note on Wednesday, November 13th. One equities research analyst has rated the stock with a hold rating and four have assigned a buy rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $199.67.

About ICU Medical

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.